Funding for this research was provided by:
Fondo de Investigaciones Sanitario (PI14/01126)
Fondo de Investigaciones Sanitario (PI17/01019, PI20/01473, PI13/01532, PI16/01825, PI18/00335, INT19/00016, PI18/00435, PI14/1561, PI17/01896)
CIBERNED program (Program 1, Alzheimer Disease)
Foundation for the National Institutes of Health (1R01AG056850–01A1, R21AG056974, R01AG061566)
Fundació la Marató de TV3 (20141210, 044412)
Generalitat de Catalunya (SLT006/17/00119, SLT002/16/00408, SLT006/17/00125)
“la Caixa” Foundation
Fondation Jérôme Lejeune
Instituto de Salud Carlos III (CP20/00038)
Received: 19 October 2021
Accepted: 19 August 2022
First Online: 3 September 2022
: The study was approved by the Sant Pau Ethics Committee following the standards for medical research in humans recommended by the Declaration of Helsinki and reported to the Ministry of Justice according to the Spanish law for research in people with intellectual disabilities. All participants or their legally authorized representative gave written informed consent before enrollment.
: Not applicable
: The authors declare that they have no competing interests.